Protalix BioTherapeutics, Inc.

Direct answer

Protalix BioTherapeutics, Inc. is publicly traded on AMEX under the ticker PLX.

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company provides Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a...

Can you invest in Protalix BioTherapeutics, Inc.?

Yes. Protalix BioTherapeutics, Inc. trades publicly on AMEX as PLX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Protalix BioTherapeutics, Inc.

Detailed equity research is provided by MarketSnap.